Lorca Laboratory

Check out our latest publication!

Bile promotes Lactobacillus johnsonii N6.2 extracellular vesicle production with conserved immunomodulatory properties - Scientific Reports Recently, Lactobacillus johnsonii N6.2-derived extracellular vesicles (EVs) were shown to reduce apoptosis in human beta cell lines and stimulate insulin secretion in human islets. Our goal was to identify a physiologically relevant environmental condition that induces a hypervesiculation phenotype....

Interested in Type 1 Diabetes Clinical Trials? - Click the Link below to Learn More!
University of Florida is currently holding two clinical trials to determine the beneficial effects of the probiotic L. johnsonii N6.2 in patients with Type 1 Diabetes.
$$ Compensation provided! $$
Must be either local to Gainesville or willing to travel to participate (Travel accommodations are available)
Criteria for adolescents:
* Ages 8-17
* Have had T1D for 1 year or less
* Willing to consume a probiotic daily for 24 weeks
* Willing to have blood drawn on 4 visits
Criteria for adults:
* Ages 18-45
* Have had T1D for 3 years or less
* Willing to consume a probiotic daily for 24 weeks
* Willing to have blood drawn on 4 visits
For more information:
https://microcell.ufl.edu/mcs-apps/lorca/trial.html
Call 352-273-5580
Email [email protected]

Lorca Laboratory We're a diverse group of researchers who study a probiotic treatment for people with Type I Diabetes